University of Texas MD Anderson Cancer Center Researchers Release New Study Findings on Breast Cancer (Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention).
In: Women's Health Weekly, 2023-10-17, S. 1313-1313
serialPeriodical
Zugriff:
For more information on this research see: Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention. Keywords: Antineoplastics; BCR-ABL Tyrosine Kinase Inhibitors; Biomarkers; Breast Cancer; Cancer; Cancer Prevention; Chemoprevention; DNA-Binding Proteins; Dasatinib Therapy; Diagnostics and Screening; Drugs and Therapies; Endocrinology; Estrogen; Estrogen Receptors; Health and Medicine; Hormones; IGF Therapy; Increlex Therapy; Insulin-Like Growth Factor; Oncology; Pharmaceuticals; Proteins; Risk and Prevention; Sprycel Therapy; Steroid Receptors; Transcription Factors; Tyrosine Kinase Inhibitors; Women's Health EN Antineoplastics BCR-ABL Tyrosine Kinase Inhibitors Biomarkers Breast Cancer Cancer Cancer Prevention Chemoprevention DNA-Binding Proteins Dasatinib Therapy Diagnostics and Screening Drugs and Therapies Endocrinology Estrogen Estrogen Receptors Health and Medicine Hormones IGF Therapy Increlex Therapy Insulin-Like Growth Factor Oncology Pharmaceuticals Proteins Risk and Prevention Sprycel Therapy Steroid Receptors Transcription Factors Tyrosine Kinase Inhibitors Women's Health 1313 1313 1 10/16/23 20231017 NES 231017 2023 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on breast cancer is the subject of a new report. [Extracted from the article]
Copyright of Women's Health Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
University of Texas MD Anderson Cancer Center Researchers Release New Study Findings on Breast Cancer (Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention).
|
---|---|
Zeitschrift: | Women's Health Weekly, 2023-10-17, S. 1313-1313 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1078-7240 (print) |
Schlagwort: |
|
Sonstiges: |
|